Colon cancer CAF migration is enhanced by TGF-β1 in a dose-dependent manner through overexpression of tight junction protein occludin, disruption of which alleviates the migration and contractile ability of TGF-β1-stimulated CAFs [105]. This evidence concerns the gene TGFB1 and malignant colon neoplasm.